A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.
Clinical trial NCT02663752 · TERMINATED
Trial details
- NCT number
- NCT02663752
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-30
- Primary completion
- 2016-07-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.